ArticleJournal of advanced research2026
Efficient derivation of stable sheep embryonic stem cells opens a new avenue for agricultural and biomedical application.
Article in Journal of advanced research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEmbryonic stem cells (ESCs), capable of generating all adult cell types, hold transformative potential for agriculture and biomedicine. However, stable sheep ESCs derivation remains challenging, limiting their application in further research.
objectivesWe aimed to establish stable sheep ESCs using a simplified protocol, validate their pluripotency, and demonstrate genome editing utility.
methodsSheep ESCs were derived from blastocyst inner cell masses via an IWR-1-containing culture system (termed TePR). Pluripotency was assessed through long-term culture (>100 passages), trilineage differentiation, transcriptomic analysis (E0-E6 embryos), and cross-species comparisons. ATAC-seq and WGBS mapped chromatin accessibility and methylation patterns, respectively. Genome editing utilized PiggyBac transposition and CRISPR/Cas9.
resultsSheep ESCs derived under TePR condition (termed TePR-sESCs) exhibited stable morphology and trilineage differentiation. Transcriptomics showed TePR-sESCs resemble 8-cell/morula embryos, consistent with sheep genome activation timing. ATAC-seq revealed accessible chromatin at pluripotency loci (e.g., POU5F1, NANOG). WGBS identified hypomethylation in pluripotency-associated regions. Efficient mCherry integration and MSTN knockouts confirmed editing compatibility.
conclusionThe TePR system enables robust derivation of sheep ESCs with embryonic-like pluripotency. TePR-sESCs' editing proficiency supports applications in livestock trait engineering and biomedical modeling, overcoming a major barrier in ungulate stem cell research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.